your badges 52W Range $2–$9 23% of range Analyst Rating HOLD 8 analysts Price Target $3 P/E -1.4 ROE -46.5% Net Profit Margin -80.2%

QTRX Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03
Price $3.64
Market Cap (MRQ) $172M
P/E (TTM) -1.4
EPS (TTM) $-2.62
Revenue (TTM) $153M
ROE (TTM) -46.5%
52W Range $2–$9

QTRX Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04
range
bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

About Quanterix Corporation - Common Stock Company overview from Wikipedia

05 · wikidata
sectorHealthcare industryLife Sciences Tools & Services employees450 countryUS

10-Year Performance Revenue, net income, margins and EPS trends

06
Revenue$139M
2022-12-31 → 2025-12-31
EPS$-2.51
2022-12-31 → 2025-12-31
Free Cash Flow$-80M
2022-12-31 → 2025-12-31
Net margin-80.2%
2022-12-31 → 2025-12-31
Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric 5Y trend QTRX 5Y avg Peer Median Verdict
P/E (TTM) -1.45Y avg ≈-16.5 ≈-16.5 · ·
P/S (TTM) 1.1 · 4.6 Undervalued
P/B (MRQ) 0.7 · 1.3 Undervalued
Price / FCF (TTM) -2.1 · · ·
Price / Cash Flow (TTM) -2.1 · · ·
Price / Tangible Book (MRQ) 1.35Y avg ≈2.1 ≈2.1 · ·

Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.

value · ≈ 5Y avg · industry median · verdict relative to median

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

14
Avg Surprise -30.0%
Next Report Nov 09, 2026
PeriodReportEPS ActualEPS EstSurprise
June 30, 2026 Aug 5, 2026 $-1.04 $-0.47 -121.7%
March 31, 2026 May 12, 2026 $-0.37 $-0.55 33.2%
Dec. 31, 2025 $-0.49 $-0.46 -6.8%
Sept. 30, 2025 $-0.73 $-0.54 -35.0%
June 30, 2025 $-0.57 $-0.37 -55.2%
March 31, 2025 $-0.42 $-0.45 5.7%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15
Income Statement 16
Metric Trend 202520242023202220212020201920182017
Revenue $139M$137M$122M$106M$111M$86M$57M$38M$23M
Cost of Revenue $74M$54M$48M$60M$46M$38M$30M$20M$13M
Gross Profit $65M$83M$74M$45M$65M$48M$27M$18M$10M
R&D Expense $36M$31M$26M$27M$28M$20M$16M$16M$16M
SG&A Expense $138M$102M$89M$92M$93M$60M$52M$34M$20M
Operating Expenses $191M$136M$120M$150M$121M$80M$68M$49M$36M
Operating Income $-126M$-53M$-46M$-104M$-57M$-32M$-42M$-32M$-26M
Other Non-op $157.0K$-136.0K$3M$-277.0K$1M$-49.0K$-10.0K$-7.0K$-63.0K
Pretax Income $-112M$-38M$-28M$-99M$-56M$-32M$-41M$-32M$-27M
Income Tax $-5M$434.0K$719.0K$164.0K$-36.0K$-376.0K$-187.0K$25.0K$0
Net Income $-107M$-39M$-28M$-100M$-56M$-32M$-41M$-32M$-27M
EPS (Basic) $-2.51$-1.00$-0.75$-2.69$-1.54$-1.07$-1.63··
EPS (Diluted) $-2.51$-1.00$-0.75$-2.69$-1.54$-1.07$-1.63··
Shares (Basic) 42,639,00038,367,00037,594,00036,991,00035,997,00029,589,13225,090,708··
Shares (Diluted) 42,639,00038,367,00037,594,00036,991,00035,997,00029,589,13225,090,708··
EBITDA $-110M·$-40M$-96M$-54M$-27M$-39M··
Balance Sheet 27
Metric Trend 202520242023202220212020201920182017
Cash & Equivalents $30M$57M$174M$339M$396M$182M$109M$44M$80M
Short-term Investments ·$0$7M$0·····
Receivables $30M$32M$25M$19M$24M$17M$11M$7M$6M
Inventory $55M$33M$26M$17M$22M$15M$10M$6M$4M
Prepaid Expense $9M$10M$9M$7M$7M$6M$2M$2M$400.0K
Current Assets $212M$364M$382M$382M$449M$220M$133M$59M$89M
PP&E (Net) $24M$17M$18M$20M$18M$14M$12M$3M$2M
PP&E (Gross) $49M$36M$32M$31M$26M$20M$16M$6M$4M
Accum. Depreciation $26M$19M$14M$11M$8M$6M$4M$3M$2M
Goodwill $26M$0$0$0$10M$10M$9M$1M·
Intangibles $132M$4M$6M$8M$11M$14M$14M$2M·
Other Non-current Assets $5M$3M$2M$911.0K$378.0K$357.0K$557.0K$536.0K$653.0K
Total Assets $419M$407M$429M$434M$502M$271M$170M$68M$92M
Accounts Payable $14M$7M$5M$4M$9M$7M$6M$5M$4M
Current Liabilities $75M$42M$39M$31M$37M$40M$20M$18M$20M
Capital Leases $29M$33M$37M$41M$20M$22M···
Deferred Tax ····$2M$3M$3M$7.0K·
Other Non-current Liabilities $8M$800.0K$1M$1M$2M$3M$13M$278.0K$144.0K
Total Liabilities $123M$76M$79M$76M$61M$65M$41M$27M$26M
Long-term Debt ·····$8M$8M$8M$9M
Total Debt ·····$8M$8M··
Common Stock $47.0K$39.0K$38.0K$37.0K$37.0K$32.0K$28.0K$22.0K$22.0K
Retained Earnings $-577M$-470M$-432M$-403M$-305M$-248M$-216M$-176M$-144M
AOCI $-723.0K$-3M$-2M$-3M$441.0K$2M$-153.0K··
Stockholders' Equity $296M$330M$350M$358M$443M$206M$129M$41M$66M
Liabilities + Equity $419M$407M$429M$434M$502M$271M$170M$68M$92M
Shares Outstanding 46,744,00038,573,00038,014,00037,280,00036,768,03531,796,54428,112,20122,369,03621,707,041
Cash Flow 14
Metric Trend 202520242023202220212020201920182017
D&A $16M$6M$6M$5M$5M$4M$3M$1M$482.0K
Stock-based Comp $21M$20M$17M$15M$16M$10M$6M$5M$2M
Deferred Tax $-6M$-286.0K$-292.0K$-295.0K$-409.0K$-491.0K$-300.0K$7.0K·
Amort. of Intangibles $8M$2M$2M$2M$2M$2M$1M$600.0K$0
Restructuring $8M··$4M·····
Other Non-cash $-1M·$-13M$28M$-11M$-6M$6M··
Operating Cash Flow $-77M$-35M$-19M$-49M$-48M$-23M$-26M$-29M$-22M
CapEx $3M$3M$4M$12M$14M$4M$11M$2M$1M
Investing Cash Flow $50M$-82M$-148M$-11M$-6M$-626.0K$-25M$-5M$-1M
Stock Issued ·······$-20.0K$8M
Financing Cash Flow $-708.0K$456.0K$3M$2M$271M$96M$116M$-78.0K$73M
Net Change in Cash ···$-57M$217M$72M$65M$-34M$50M
Taxes Paid $1M········
Free Cash Flow $-80M·$-23M$-60M$-62M$-27M$-37M··
Profitability 8
Metric Trend 202520242023202220212020201920182017
Gross Margin 46.8%·60.7%44.4%55.8%55.8%47.3%··
Operating Margin -90.4%·-37.6%-96.4%-53.0%-36.6%-73.3%··
Net Margin -77.1%·-23.2%-91.6%-52.2%-36.5%-71.9%··
Pretax Margin -80.8%·-22.6%-91.6%-52.2%-36.9%-72.2%··
EBITDA Margin -79.0%·-32.5%-91.3%-48.6%-31.6%-68.0%··
ROA -26.0%··-22.0%-14.9%-14.3%-34.4%··
ROE -36.4%··-26.5%-12.9%-15.2%-30.8%··
ROIC -40.5%··-28.3%-13.3%-14.6%-30.4%··
Liquidity & Solvency 4
Metric Trend 202520242023202220212020201920182017
Current Ratio 2.8··12.312.15.56.7··
Quick Ratio 0.8··11.611.45.06.1··
Debt / Equity ·····0.00.1··
LT Debt / Equity ······0.1··
Efficiency 3
Metric Trend 202520242023202220212020201920182017
Asset Turnover 0.3··0.20.30.40.5··
Inventory Turnover 1.7··3.42.63.03.6··
Receivables Turnover 4.5··5.75.46.26.4··
Per Share 5
Metric Trend 202520242023202220212020201920182017
Book Value / Share $6.33··$9.63$11.99$6.48$4.58··
Revenue / Share $3.26·$3.25$2.85$3.07$2.92···
Cash Flow / Share $-1.81·$-0.50$-1.30$-1.33$-0.79···
Cash / Share $0.64··$9.09$10.78$5.71$3.88··
EPS (TTM) $-2.51$-1.00$-0.75$-2.69$-1.54$-1.07$-1.63··
Growth Rates 3
Metric Trend 202520242023202220212020201920182017
Revenue YoY 1.1%12.3%16.0%-4.5%28.0%····
Revenue CAGR 3Y 9.6%7.5%12.3%······
Revenue CAGR 5Y 10.0%········
Valuation (TTM) 14
Metric Trend 202520242023202220212020201920182017
Revenue TTM $139M$137M$122M$106M$111M$86M$57M$38M$23M
Net Income TTM $-107M$-39M$-28M$-100M$-56M$-32M$-41M$-32M$-27M
Market Cap $297M··$516M$1.56B$1.48B$664M··
Enterprise Value ·····$1.30B$563M··
P/E -2.5-10.6-36.5-5.1-27.5-43.5-14.5··
P/S 2.1··4.914.117.111.7··
P/B 1.0··1.43.57.25.2··
P / Tangible Book 2.21.33.01.53.78.1···
P / Cash Flow -3.8··-10.7-32.5-63.3-25.4··
P / FCF -3.7··-8.6-25.3-54.2-17.9··
EV / EBITDA ·····-47.8-14.6··
EV / FCF ·····-47.8-15.2··
EV / Revenue ·····15.19.9··
Earnings Yield -39.5%-9.4%-2.7%-19.4%-3.6%-2.3%-6.9%··

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16
Metric 2025-12-312024-12-312023-12-312023-09-302023-06-30
Revenue $139M $137M $122M · ·
Gross Margin % 46.8% · 60.7% · ·
Operating Margin % -90.4% · -37.6% · ·
Net Income $-107M $-39M $-28M · ·
Diluted EPS $-2.51 $-1.00 $-0.75 · ·

Institutional owners (13F) 144 filers · $145.5M total · As of June 30, 2026

17

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Holders 144
Value held $145.5M
New positions 39
Exited positions 31
Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
39 (+16 vs prior Q) 31 (+11 vs prior Q) 44 (-5 vs prior Q) 29 (-5 vs prior Q) -4.6M

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
VANGUARD GROUP INC $17,031,018 2,677,833 11.71% Shares
BlackRock, Inc. $15,704,976 3,635,411 10.80% Shares
Blue Water Life Science Advisors, LP $15,008,553 3,474,202 10.32% Shares
First Eagle Investment Management, LLC $11,893,673 2,753,165 8.18% Shares
Portolan Capital Management, LLC $8,205,011 1,899,308 5.64% Shares
VANGUARD CAPITAL MANAGEMENT LLC $7,778,782 1,800,644 5.35% Shares
AQR CAPITAL MANAGEMENT LLC $5,801,782 1,343,005 3.99% Shares
Kent Lake PR LLC $5,435,430 1,001,000 3.74% Shares
GEODE CAPITAL MANAGEMENT, LLC $4,888,805 1,131,377 3.36% Shares
AMERIPRISE FINANCIAL INC $4,265,671 987,424 2.93% Shares
MARSHALL WACE, LLP $4,207,125 973,872 2.89% Shares
STATE STREET CORP $4,027,566 932,307 2.77% Shares
Tikvah Management LLC $2,469,118 571,555 1.70% Shares
VANGUARD PORTFOLIO MANAGEMENT LLC $2,114,925 489,566 1.45% Shares
JACOBS LEVY EQUITY MANAGEMENT, INC $2,106,432 487,600 1.45% Shares
MORGAN STANLEY $1,934,013 447,688 1.33% Shares
JANE STREET GROUP, LLC $1,810,296 419,050 1.24% Shares
TUDOR INVESTMENT CORP ET AL $1,729,737 400,402 1.19% Shares
DIMENSIONAL FUND ADVISORS LP $1,719,314 397,833 1.18% Shares
Cubist Systematic Strategies, LLC $1,707,290 314,418 1.17% Shares
NORTHERN TRUST CORP $1,456,820 337,227 1.00% Shares
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $1,342,228 310,701 0.92% Shares
VANGUARD FIDUCIARY TRUST CO $1,245,504 288,311 0.86% Shares
UBS Group AG $1,218,145 281,978 0.84% Shares
Balyasny Asset Management L.P. $1,123,200 260,000 0.77% Call option
Nuveen, LLC $1,004,798 232,592 0.69% Shares
CITADEL ADVISORS LLC $992,460 229,736 0.68% Shares
XTX Topco Ltd $985,111 228,035 0.68% Shares
Point72 Asset Management, L.P. $974,821 225,653 0.67% Shares
GOLDMAN SACHS GROUP INC $916,082 212,056 0.63% Shares
FMR LLC $909,940 210,634 0.63% Shares
IRONWOOD INVESTMENT MANAGEMENT LLC $736,798 170,555 0.51% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $728,439 168,620 0.50% Shares
Invesco Ltd. $695,032 160,887 0.48% Shares
WELLS FARGO & COMPANY/MN $644,362 149,158 0.44% Shares
Susquehanna Portfolio Strategies, LLC $642,030 148,618 0.44% Shares
BNP PARIBAS FINANCIAL MARKETS $591,304 136,876 0.41% Shares
Bank of New York Mellon Corp $569,808 131,900 0.39% Shares
TWO SIGMA ADVISERS, LP $552,620 86,890 0.38% Shares
SCS Capital Management LLC $518,551 120,035 0.36% Shares
AMERICAN CENTURY COMPANIES INC $434,000 100,463 0.30% Shares
JNB Advisors LLC $432,250 65,000 0.30% Shares
Clarius Group, LLC $404,011 62,060 0.28% Shares
Quadrature Capital Ltd $346,464 80,200 0.24% Shares
Cerity Partners LLC $337,319 78,083 0.23% Shares
BRIDGEWAY CAPITAL MANAGEMENT, LLC $294,736 68,226 0.20% Shares
Clearstead Advisors, LLC $268,969 62,261 0.18% Shares
Jain Global LLC $247,618 57,319 0.17% Shares
ALGERT GLOBAL LLC $238,537 55,217 0.16% Shares
RHUMBLINE ADVISERS $231,358 53,557 0.16% Shares

Show all 144 institutional owners →

Activists & 5%+ owners 3 positions

18

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
Kent Lake Partners LP, Kent Lake PR LLC, Benjamin Natter, Alexander G. Dickinson, Bruce Felt, Hakan Sakul ×3 filings July 15, 2025 4.50% Amendment Board campaign SEC
Akoya Biosciences, Inc. ×2 filings April 30, 2025 0.00% Amendment · SEC
Quanterix Corporation ×2 filings April 30, 2025 55.60% Amendment M&A / sale SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Company insiders 40 insiders · 21 officers · 21 directors

19
Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Everett Cunningham President and CEO Jan. 19, 2026 A · 0 0 $0
Masoud Toloue President & CEO Jan. 15, 2026 F 507,310 0 0 $0
Jason F. Faessler Chief Financial Officer July 15, 2026 A · 0 0 $0
Vandana Sriram Chief Financial Officer June 15, 2026 M 31,283 0 0 $0
Michael A Doyle CFO and Treasurer Sept. 30, 2023 F 88,332 0 0 $0
Shawn Stetson Interim CFO and Treasurer May 11, 2021 A 4,712 0 0 $0
Amol Chaubal Chief Financial Officer May 3, 2021 S 30,222 0 0 $0
Joseph Driscoll Chief Financial Officer Jan. 15, 2019 M 4,388 0 0 $0
William Geist Chief Operating Officer Feb. 8, 2021 A 44,951 0 0 $0
James Edward Gute Jr. Chief Commercial Officer Sept. 15, 2026 A · 0 0 $0
Michael Francis Miller Chief Technology Officer Sept. 15, 2026 M 38,452 0 0 $0
Benjamin Meadows Chief Commercial Officer May 12, 2026 P 3,500 1 0 $9,695
John J Fry General Counsel & Secretary Aug. 1, 2022 S 37,671 0 0 $0
Kevin E Hrusovsky Executive Chairman July 5, 2022 S 910,249 0 0 $0
Dawn Mattoon Sr. VP, Diagnostics April 1, 2022 S 36,876 0 0 $0
Mark T. Roskey SVP, Strategic Partnerships April 1, 2022 S 22,325 0 0 $0
David C. Duffy SVP R&D and CTO March 23, 2022 S 54,730 0 0 $0
Amee Desjourdy Chief Human Resource Officer Aug. 19, 2019 A 11,834 0 0 $0
Jackson Streeter SVP, Corp Dev & Strategy March 17, 2019 A 32,515 0 0 $0
Ernest Orticerio SVP Finance and Corporate Dev Jan. 9, 2019 M 48,802 0 0 $0
Bruce J Bal VP of Ops, Service and Quality May 10, 2018 A 5,485 0 0 $0
Ivana Magovcevic-Liebisch Director Oct. 2, 2026 M 15,883 0 0 $0
Scott Mendel Director Oct. 1, 2026 A 28,454 0 0 $0
William P Donnelly Director Oct. 1, 2026 A 169,365 2 0 $286,354
Jeffrey Thomas Elliott Director Aug. 19, 2026 M 15,345 0 0 $0
Goldman Myla Lai Director July 8, 2026 M 15,041 0 0 $0
Alan Bruce Sachs Director Jan. 2, 2026 A 70,099 0 0 $0
Malcolm Garret Hampton Director Jan. 2, 2026 A 70,099 0 0 $0
Karen Flynn Director Jan. 2, 2026 A 57,212 0 0 $0
David R Walt Director Jan. 2, 2026 A 1,872,890 0 0 $0
Paul M Meister Director Jan. 2, 2026 A 313,253 0 0 $0
Sarah H Mcconnell Director July 1, 2025 A 60,070 0 0 $0
Martin D Madaus Director Jan. 2, 2025 A 36,908 0 0 $0
Laurie J Olson Director May 14, 2024 S 13,738 0 0 $0
Brian J Blaser Director Jan. 2, 2024 A 19,049 0 0 $0
Keith Crandell Director April 3, 2023 A 131,236 0 0 $0
Marijn E Dekkers Director June 7, 2021 M 2,270 0 0 $0
John M Connolly Director Jan. 2, 2020 A 9,510 0 0 $0
Douglas G. Cole Director Jan. 2, 2019 A 4,540 0 0 $0
bioMerieux/ADR 10% owner Dec. 11, 2017 C 2,055,632 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

ETF ownership Held by 15 ETFs

20

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
QQQS · Invesco Exchange-Traded Fund Trust … 0.67% 44,909 SH Oct. 2, 2026 Daily
IWC · iShares Trust 0.02% 142,456 SH Sept. 11, 2026 Daily
PRFZ · Invesco Exchange-Traded Fund Trust 0.01% 93,704 SH Oct. 2, 2026 Daily
OMFS · Invesco Exchange-Traded Self-Indexe… 0.01% 8,458 SH Oct. 2, 2026 Daily
VTWO · VANGUARD SCOTTSDALE FUNDS 0.01% 245,120 SH Aug. 19, 2026 Daily
VTWV · VANGUARD SCOTTSDALE FUNDS 0.01% 38,088 SH Aug. 19, 2026 Daily
IBB · iShares Trust 0.01% 298,897 SH Sept. 11, 2026 Daily
RSSL · Global X Funds 0.00% 20,407 NS July 31, 2026 N-PORT
IWM · iShares Trust 0.00% 1,103,537 SH Sept. 11, 2026 Daily
IWV · iShares Trust 0.00% 12,646 SH Sept. 3, 2026 Daily
VXF · VANGUARD INDEX FUNDS 0.00% 500,146 SH Aug. 19, 2026 Daily
VTI · VANGUARD INDEX FUNDS 0.00% 1,254,850 SH Aug. 19, 2026 Daily
VTHR · VANGUARD SCOTTSDALE FUNDS 0.00% 3,970 SH Aug. 19, 2026 Daily
VHT · VANGUARD WORLD FUND 0.00% 111,700 SH Aug. 19, 2026 Daily
IWN · iShares Trust · 389,677 SH Sept. 11, 2026 Daily

QTRX Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

21
rating · 8 analysts SELL
Median target $3.00 -17.6%
0 0.0% Strong Buy
0 0.0% Buy
5 62.5% Hold
1 12.5% Sell
2 25.0% Strong Sell

12-Month Price Target

3 analysts · 2026-10-03

Mean target $3.00 -17.6%

Low$3.00 Mean$3.00 High$3.00

Peer comparison (GICS sub-industry) Key metrics vs sector peers

22

FY basis, prices as of each company's last fiscal year-end close.

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
QTRX $297M -2.5 1.1% -77.1% -36.4% 46.8%
TKNO $204M -11.9 7.3% -42.6% -23.8% 33.2%
QSI · · · · · ·
LAB $495M -6.4 -6.2% -87.8% -17.6% 49.9%
LFCR $249M -5.3 0.47% -30.0% -461.3% 31.3%
NAUT $247M -4.1 · · -34.9% ·
CDXS $147M -3.3 18.6% -62.5% -82.8% ·
SEER · -1.4 17.0% · · ·
MXCT $166M -3.7 -14.5% -135.1% -24.6% 81.2%
CSBR $83M -74.5 4.4% -2.0% -30.5% ·
HYFT · · · -89.7% -78.9% 58.8%

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Source: SEC 10-Q filed Aug 10, 2026